-
1.
Intracavitary offline "in vivo" dosimetry for high dose-rate prostate brachytherapy with Ir-192: development of technology and first results of its application
-
(«Radiation and Risk», 2017, vol. 26, No. 2)
-
Stepanenko V.F., Biryukov V.A., Kaprin A.D.1, Galkin V.N., Ivanov S.A., Kariakin O.B., Mardinskiy Yu.S., Gulidov I.A., Kolyzhenkov T.V., Ivannikov A.I., Borysheva N.B., Skvortsov V.G., Akhmedova U.A., ...
-
2.
Local absorbed doses of irradiation of medical personnel at brachytherapy of prostate cancer using I-125 microsources of Russian production
-
(«Radiation and Risk», 2017, vol. 26, No. 1)
-
Stepanenko V.F., Biryukov V.A., Karjakin O.B., Kaprin A.D., Galkin V.N., Ivanov S.A., Mardinskiy Yu.S., Kolyzhenkov T.V., Petukhov A.D., Bogacheva V.V., Akhmedova U.A., Yaskova E.K., Lepilina O.G., Sanin ...
-
3.
In vivo dosimetry at high dose rate brachytherpapy for prostate cancer using Ir-192: comparison of dose distribution between planned and measured doses with intracavi-tary placement of autonomous luminescence microdosimeters
-
(«Radiation and Risk», 2018, vol. 27, No. 1)
-
Stepanenko V.F., Biryukov V.A., Kaprin A.D.1, Galkin V.N., Ivanov S.A.1, Borysheva N.B., Kariakin O.B., Mardinskiy Yu.S., Gulidov I.A., Kolyzhenkov T.V., Obukhov A.A., Ivannikov A.I., Skvortsov V.G., Akhmedova ...
